{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T22:27:51Z","timestamp":1782167271409,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.humpath.2010.10.011","type":"journal-article","created":{"date-parts":[[2011,2,3]],"date-time":"2011-02-03T09:15:29Z","timestamp":1296724529000},"page":"972-982","source":"Crossref","is-referenced-by-count":8,"title":["Differential expression of cell-cycle regulatory proteins defines distinct classes of follicular lymphoma"],"prefix":"10.1016","volume":"42","author":[{"given":"Abdulmohsen","family":"Alhejaily","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianne","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl J.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia L.","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Blake","family":"Gilks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Brettschneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet E.","family":"Feilotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Baetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"LeBrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2010.10.011_bb0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2010.10.011_bb0010","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1200\/JCO.1997.15.4.1587","article-title":"Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients","volume":"15","author":"Bastion","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2010.10.011_bb0015","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/jnci\/djj371","article-title":"Idiotype vaccination in follicular lymphoma: knocking on the doorway to cure","volume":"98","author":"Longo","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2010.10.011_bb0020","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group classification of non\u2013Hodgkin's lymphoma. The Non\u2013Hodgkin's Lymphoma Classification Project","volume":"89","author":"The Non\u2013Hodgkin's Lymphoma Classification Project","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2010.10.011_bb0025","doi-asserted-by":"crossref","first-page":"483","DOI":"10.5858\/2006-130-483-GEPDIL","article-title":"Gene expression profiling data in lymphoma and leukemia: review of the literature and extrapolation of pertinent clinical applications","volume":"130","author":"Dunphy","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2010.10.011_bb0030","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMcibr067155","article-title":"A closer look at follicular lymphoma","volume":"356","author":"Staudt","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2010.10.011_bb0035","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1038\/sj.onc.1209615","article-title":"RB and cell cycle progression","volume":"25","author":"Giacinti","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2010.10.011_bb0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/modpathol.3880035","article-title":"The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997","volume":"13","author":"Harris","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2010.10.011_bb0045","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/path.1838","article-title":"Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry","volume":"207","author":"Nenutil","year":"2005","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2010.10.011_bb0050","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.leu.2403802","article-title":"A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma","volume":"19","author":"Davies","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2010.10.011_bb0055","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1182\/blood.V82.8.2289.2289","article-title":"p53 mutations are associated with histologic transformation of follicular lymphoma","volume":"82","author":"Lo","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2010.10.011_bb0060","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1182\/blood.V82.7.1994.1994","article-title":"p53 mutation is associated with progression in follicular lymphomas","volume":"82","author":"Sander","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2010.10.011_bb0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/00313020400011334","article-title":"p53 alterations in sequential biopsies of Asian follicular lymphoma: a study of immunohistochemical staining pattern and gene mutations by PCR-SSCP in paraffin-embedded tissues","volume":"37","author":"Shaminie","year":"2005","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2010.10.011_bb0070","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/(SICI)1096-9896(199707)182:3<307::AID-PATH873>3.0.CO;2-6","article-title":"bcl-2 and p53 protein expression in follicular lymphoma","volume":"182","author":"Cooper","year":"1997","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2010.10.011_bb0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00129039-200406000-00001","article-title":"Immunophenotypic and genotypic characterization of progression in follicular lymphomas","volume":"12","author":"Natkunam","year":"2004","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2010.10.011_bb0080","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1078\/0344-0338-00421","article-title":"Disappearance of CD21-positive follicular dendritic cells preceding the transformation of follicular lymphoma: immunohistological study of the transformation using CD21, p53, Ki-67, and P-glycoprotein","volume":"199","author":"Shiozawa","year":"2003","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.humpath.2010.10.011_bb0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1385\/MO:18:1:15","article-title":"Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large B-cell lymphoma","volume":"18","author":"Llanos","year":"2001","journal-title":"Med Oncol"},{"key":"10.1016\/j.humpath.2010.10.011_bb0090","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0609.2008.01113.x","article-title":"Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma","volume":"81","author":"Pennanen","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.humpath.2010.10.011_bb0095","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1200\/JCO.1998.16.3.1197","article-title":"Role of the p16 tumor suppressor gene in cancer","volume":"16","author":"Liggett","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2010.10.011_bb0100","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1182\/blood.V91.12.4677","article-title":"Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma","volume":"91","author":"Elenitoba-Johnson","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2010.10.011_bb0105","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1182\/blood.V91.8.2977.2977_2977_2984","article-title":"p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non\u2013Hodgkin's lymphomas","volume":"91","author":"Pinyol","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2010.10.011_bb0110","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0002-9440(10)65630-1","article-title":"Loss of p16\/INK4A protein expression in non\u2013Hodgkin's lymphomas is a frequent finding associated with tumor progression","volume":"153","author":"Villuendas","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2010.10.011_bb0115","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrm1987","article-title":"Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all","volume":"7","author":"Gil","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.humpath.2010.10.011_bb0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0959-437X(02)00013-8","article-title":"Tumor suppression by Ink4a-Arf: progress and puzzles","volume":"13","author":"Lowe","year":"2003","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.humpath.2010.10.011_bb0125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1126\/science.7809631","article-title":"Inhibition of ras-induced proliferation and cellular transformation by p16INK4","volume":"267","author":"Serrano","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.humpath.2010.10.011_bb0130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0092-8674(00)81079-X","article-title":"Role of the INK4a locus in tumor suppression and cell mortality","volume":"85","author":"Serrano","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2010.10.011_bb0135","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/sj.leu.2402644","article-title":"Proliferation-dependent expression and phosphorylation of pRB in B cell non\u2013Hodgkin's lymphomas: dependence on RB1 copy number","volume":"16","author":"Galteland","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2010.10.011_bb0140","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/path.1711690404","article-title":"Retinoblastoma (Rb) gene product expression in lymphomas. Correlation with Ki67 growth fraction","volume":"169","author":"Martinez","year":"1993","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2010.10.011_bb0145","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/ajcp\/105.5.538","article-title":"Immunohistochemical detection of p53, bcl-2, and retinoblastoma proteins in follicular lymphoma","volume":"105","author":"Nguyen","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2010.10.011_bb0150","first-page":"1139","article-title":"Lack of nuclear RB protein staining in G0\/middle G1 cells: correlation to changes in total RB protein level","volume":"6","author":"Xu","year":"1991","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2010.10.011_bb0155","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1309\/8KF0-0Y0C-2F4L-UHXL","article-title":"Cyclin D3 expression in non\u2013Hodgkin lymphoma. Correlation with other cell cycle regulators and clinical features","volume":"115","author":"Moller","year":"2001","journal-title":"Am J Clin Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817710003928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817710003928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T12:47:10Z","timestamp":1637239630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817710003928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0046817710003928"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2010.10.011","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}